Artificial Tears Market Witnesses Robust Expansion Amid Rising Dry Eye Prevalence United States of America– 24 Dec 2025- The artificial tears market continues to expand rapidly, propelled by increasing incidences of dry eye conditions linked to modern lifestyles and demographic shifts. Key players innovate with advanced formulations to address consumer demands for effective relief, positioning the sector for sustained growth. This press release explores market drivers, segmentation, regional dynamics, and strategic developments shaping the landscape. The artificial tears market size is projected to reach US$ 4.85 billion by 2031 from US$ 2.98 billion in 2023. The market is expected to register a CAGR of 7.2% during 2023–2031. Lifestyle changes will likely remain a key trend in the market. For more information- https://www.theinsightpartners.com/reports/artificial-tears-market Market Drivers Rising dry eye prevalence stands as the primary catalyst, exacerbated by prolonged screen exposure, environmental pollutants, and lifestyle changes in urban settings. Aging populations worldwide heighten vulnerability, as degenerative eye changes become more common among older demographics, prompting greater reliance on lubricating solutions. Industrial advancements, including preservative-free and viscoadaptive options, further accelerate adoption by offering superior hydration and comfort for chronic conditions. Contact lens usage amplifies demand, with wearers frequently experiencing irritation that necessitates regular lubrication. Heightened awareness through public health campaigns and digital media educates consumers on proactive eye care, expanding over-the-counter accessibility. These factors collectively foster a dynamic environment where manufacturers prioritize efficacy and convenience to capture emerging opportunities. Download PDF Copy- https://www.theinsightpartners.com/sample/TIPRE00004073 Segmentation Insights The market segments by type into cellulose-derived, glycerin-derived, oil-based emulsion, polyethylene glycol-based, propylene glycol-based, and sodium hyaluronate-based tears, with glycerin-derived variants leading due to their prolonged lubrication properties. Delivery modes primarily comprise eye drops and ointments, where eye drops dominate owing to user preference for quick application and minimal blur. Applications focus on dry eye treatment and contact lens moisture, with the former commanding the largest share as it addresses the core therapeutic need. Glycerin-derived and eye drop formats appeal broadly for their balance of hydration and ease, particularly in daily routines. Oil-based emulsions gain traction for severe evaporative dry eye, mimicking natural tear films more effectively. This segmentation reflects tailored innovations aligning with diverse consumer profiles, from mild discomfort to intense symptoms.